F. Worden

485 total citations
11 papers, 390 citations indexed

About

F. Worden is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, F. Worden has authored 11 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Otorhinolaryngology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in F. Worden's work include Head and Neck Cancer Studies (6 papers), Sarcoma Diagnosis and Treatment (2 papers) and MRI in cancer diagnosis (2 papers). F. Worden is often cited by papers focused on Head and Neck Cancer Studies (6 papers), Sarcoma Diagnosis and Treatment (2 papers) and MRI in cancer diagnosis (2 papers). F. Worden collaborates with scholars based in United States, Australia and Germany. F. Worden's co-authors include Douglas B. Chepeha, Avraham Eisbruch, Gregory T. Wolf, Carol R. Bradford, Johann S. de Bono, Antonio Gualberto, Paul Haluska, M. Luisa Paccagnella, David Olmos and Donghua Yin and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

F. Worden

10 papers receiving 381 citations

Peers

F. Worden
Raymond King‐Yin Tsang Hong Kong
Bernardo Goulart United States
Yan Mao China
Amna Khurshid Pakistan
Gabriel Calzada United States
Yanfen Feng China
Yungpo Bernard Su United States
Hui‐Ping Chien Taiwan
Kristoff Muylle Belgium
Xiaoshuai Yuan China
Raymond King‐Yin Tsang Hong Kong
F. Worden
Citations per year, relative to F. Worden F. Worden (= 1×) peers Raymond King‐Yin Tsang

Countries citing papers authored by F. Worden

Since Specialization
Citations

This map shows the geographic impact of F. Worden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Worden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Worden more than expected).

Fields of papers citing papers by F. Worden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Worden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Worden. The network helps show where F. Worden may publish in the future.

Co-authorship network of co-authors of F. Worden

This figure shows the co-authorship network connecting the top 25 collaborators of F. Worden. A scholar is included among the top collaborators of F. Worden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Worden. F. Worden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Rosen, Benjamin, Madhava Aryal, Yang Cao, et al.. (2022). Early Toxicity and Patient Reported Outcomes From a Phase 2 Trial of FDG-PET Response-Based De-Escalated Definitive Radiotherapy for p16+ Oropharynx Cancer. International Journal of Radiation Oncology*Biology*Physics. 112(5). e3–e3.
2.
Hawkins, Peter G., Jae Lee, C. Lee, et al.. (2018). Adaptive Chemoradiation Therapy for Head and Neck Cancer Based on Multiparametric MRI: Interim Results of a Prospective Randomized Trial. International Journal of Radiation Oncology*Biology*Physics. 100(5). 1319–1320. 1 indexed citations
3.
Sabolch, Aaron, Tobias Else, Andrew Williams, et al.. (2014). Toxicity of Concurrent Radiation Therapy With Mitotane Compared to Radiation Therapy Alone in the Adjuvant Treatment of Adrenocortical Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 90(1). S466–S467. 1 indexed citations
4.
Imai, Atsushi, Benjamin D. Zeitlin, Fernanda Visioli, et al.. (2011). Metronomic Dosing of BH3 Mimetic Small Molecule Yields Robust Antiangiogenic and Antitumor Effects. Cancer Research. 72(3). 716–725. 14 indexed citations
5.
Light, Emily, F. Worden, Mark E. Prince, et al.. (2010). Correlation of Cellular Immunity With Human Papillomavirus 16 Status and Outcome in Patients With Advanced Oropharyngeal Cancer. Archives of Otolaryngology - Head and Neck Surgery. 136(12). 1267–1267. 95 indexed citations
6.
Haluska, Paul, F. Worden, David Olmos, et al.. (2009). Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma. Cancer Chemotherapy and Pharmacology. 65(4). 765–773. 152 indexed citations
7.
Chepeha, Douglas B., Assuntina G. Sacco, Lance Oxford, et al.. (2009). Advanced squamous cell carcinoma of the oropharynx: Efficacy of positron emission tomography and computed tomography for determining primary tumor response during induction chemotherapy. Head & Neck. 31(4). 452–460. 15 indexed citations
8.
Postel‐Vinay, Sophie, Shingo Okuno, Scott M. Schuetze, et al.. (2008). 388 POSTER Safety, pharmacokinetics and preliminary activity of the anti-IGF-IR antibody CP-751,871 in patients with sarcoma. European Journal of Cancer Supplements. 6(12). 122–122. 5 indexed citations
9.
Gandhi, Dheeraj, Douglas B. Chepeha, Talia Miller, et al.. (2006). Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy.. PubMed. 27(1). 101–6. 96 indexed citations
10.
Chugh, Rashmi, Dafydd G. Thomas, T. Wagner, et al.. (2005). Pharmacokinetics of ifosfamide and cytochrome P450 3A in a phase II trial of doxorubicin and ifosfamide in sarcoma patients. Journal of Clinical Oncology. 23(16_suppl). 2035–2035. 1 indexed citations
11.
Wolf, Gregory T., Carol R. Bradford, Susan G. Urba, et al.. (2002). Immune Reactivity Does Not Predict Chemotherapy Response, Organ Preservation, or Survival in Advanced Laryngeal Cancer. The Laryngoscope. 112(8). 1351–1356. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raymond King‐Yin Tsang Breakdown of academic impact, for papers by Bernardo Goulart Breakdown of academic impact, for papers by Yan Mao Breakdown of academic impact, for papers by Amna Khurshid Breakdown of academic impact, for papers by Gabriel Calzada Breakdown of academic impact, for papers by Yanfen Feng Breakdown of academic impact, for papers by Yungpo Bernard Su Breakdown of academic impact, for papers by Hui‐Ping Chien Breakdown of academic impact, for papers by Kristoff Muylle Breakdown of academic impact, for papers by Xiaoshuai Yuan
Rankless by CCL
2026